Classes
- Internal Medicine - SE +1B00073 | First Faculty of Medicine
- Internal Medicine - Hematology +1B00307 | First Faculty of Medicine
- Review of Internal Diseases 1B00341 | First Faculty of Medicine
- Review of Internal Diseases 2B00355 | First Faculty of Medicine
- Ultrasonographic and Endoscopic TechnologyB00816 | First Faculty of Medicine
- Internal Medicine Practice before State Examination +1B01056 | First Faculty of Medicine
- Review of Internal Medicine - Rehabilitation 1B01536 | First Faculty of Medicine
- Diagnosis and therapy in haematology - ethical issuesB02094 | First Faculty of Medicine
- Laboratory Methods in Hematology - Diagnostic Tool and Translation´s Research +1B02551 | First Faculty of Medicine
- News in hematology and blood transfusionB02697 | First Faculty of Medicine
Publications
- No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Alterations of CHEK2 forkhead-associated domain increase the risk of Hodgkin lymphoma2011 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia2011 | First Faculty of Medicine
- New prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice : an analysis of data from four hematology departments2010 | First Faculty of Medicine
- Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction2010 | First Faculty of Medicine
- Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia2008 | First Faculty of Medicine
- Alterations of CHEK2 gene in non-Hodgkin lymphoma patientsPublication without faculty affiliation
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Characterization of the input material quality for the production of tisagenlecleucel by multiparameter flow cytometry and its relation to the clinical outcome2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
Loading network view...